Moderna Inc. (NASDAQ: MRNA) was the second company to receive emergency approval for a Coronavirus vaccine in the United States. With a highly effective vaccine that is preferred by the federal government, the company has shifted gear in recent months to improve its delivery targets.
In its latest update, Moderna says that it will deliver 100 million doses to the U.S. government by the end of next month.
Moderna Vaccine Release Schedule
Moderna’s vaccine will be distributed to the federal government, which then distributes to states based on a priority system that is constantly evolving. Moderna will deliver hundreds of millions of doses over the next few months.
- 100 million doses will be delivered before the end of March.
- Another 100 million will be delivered before the end of July.
More than 45 million doses have already been delivered and 25.5 million of these have been administered, according to the CDC. The Moderna vaccine requires two doses spread weeks apart, so the 200 million being delivered later this year will be enough to vaccinate 100 million people.
Moderna’s latest update pushes the delivery target forward. It previously estimated that it would deliver 100 million doses at the end of July, and then another lot at the end of September.
Vaccinations are Key to Economic Recovery
Moderna will see a huge revenue boost from its vaccines in the United States and abroad. The company is currently a popular stock pick for investors looking to profit from the pharmaceutical response to COVID-19.
Experts believe that vaccinating the entire world should be a priority right now. In the United States, the government is pushing to vaccinate all healthy people at ages ranging from teens to senior citizens. With vaccinations, a type of herd immunity will be developed, stopping the spread of the deadly virus. By vaccinating most of the population, even those who don’t receive shots will be protected.
Mass vaccinations will allow for the relaxing of travel restrictions, social gatherings, and large public gatherings.
Unemployment in the U.S. is still above 6%. More vaccinations could help to boost the economy and more jobs could be added. Long-term, vaccines like the one produced by Moderna will benefit investors because stocks are likely to gain value as the health crisis stabilizes.
Moderna remains a strong investment option today, thanks to its valuable government contracts and direct involvement in stopping the spread of the Coronavirus.
You may be interested
Job Hiring is Picking Up as Employers and Consumers Gain ConfidenceLamont J - March 29, 2021
The recent government stimulus for small and medium-sized businesses, personal stimulus checks, and declining Coronavirus cases, are all great news…
Fed Could Maintain 0% Interest Rate Until 2024Adam R - March 26, 2021
The Federal Reserve is holding its target interest rate in a range of 0.00% - 0.25%, even while the economy…